The Long-Term Safety of Adalimumab Treatment in Moderate to Severe Psoriasis: A Comprehensive Analysis of All Adalimumab Exposure in All Clinical Trials

Author： Leonardi Craig  

Publisher： Adis International

ISSN： 1175-0561

Source： American Journal of Clinical Dermatology, Vol.12, Iss.5, 2011-10, pp. : 321-337

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-Term Treatment of Severe SAPHO Syndrome with Adalimumab: Case Report and a Review of the Literature

By Garcovich Simone  

American Journal of Clinical Dermatology, Vol. 13, Iss. 1, 2012-02 ,pp. : 55-59

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Adalimumab among Patients with Moderate to Severe Psoriasis with Co-Morbidities: Subanalysis of Results from a Randomized, Double-Blind, Placebo-Controlled, Phase III Trial

By Kimball Alexa B.  

American Journal of Clinical Dermatology, Vol. 12, Iss. 1, 2011-02 ,pp. : 51-62

Adis International

Access to resources Recommend Favorite

Adalimumab: In Plaque Psoriasis

By Croom Katherine F.   McCormack Paul L.  

American Journal of Clinical Dermatology, Vol. 10, Iss. 1, 2009-01 ,pp. : 43-50

Adis International

Access to resources Recommend Favorite

Safety and Efficacy of Subcutaneously Administered Efalizumab in Adults with Moderate-to-Severe Hand and Foot Psoriasis: An Open-Label Study

By Varma Rajat   Cafardi Jennifer A.   Cantrell Wendy   Elmets Craig  

American Journal of Clinical Dermatology, Vol. 9, Iss. 2, 2008-01 ,pp. : 105-109

Adis International

Access to resources Recommend Favorite

A Comprehensive Review of the Long-Term and Short-Term Treatment of Melasma with a Triple Combination Cream

By Torok Helen M.  

American Journal of Clinical Dermatology, Vol. 7, Iss. 4, 2006-01 ,pp. : 223-230

Adis International

Access to resources Recommend Favorite